Nephrocare Health Services Limited (NSEI: NEPHROPLUS)
Health Care · Health Care Providers & Services · IN
Rs648.95
-6.85% today · +37.7% 1Y
Nephrocare Health Services Limited (NSEI: NEPHROPLUS) operates in the Health Care Providers & Services industry within the Health Care sector. The company is valued at $676.32M.
Over the last twelve months the share price has gained 37.7%, trading between 446.00 and 781.50.
Tweenvest scores Nephrocare Health Services Limited across four factors: quality 75/100, value 27/100, growth 100/100. Its strongest factor is growth.
NEPHROPLUS price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $676.32M
- Revenue (TTM)
- $111.35M
- P/E
- 75.19
- EPS
- 8.63
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- Rs781.50
- 52-week low
- Rs446.00
- Avg volume (3M)
- —
- Shares outstanding
- 100.34M
- Employees
- —
- Next earnings
- —
Other Health Care Providers & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Bright Eye Hospital Group Co., Ltd.SZSE: 301239 | $709.72M | CN¥31.98 | +1.52% |
| Middle East Healthcare CompanySASE: 4009 | $691.80M | SR28.22 | -2.82% |
| PT Metro Healthcare Indonesia TbkIDX: CARE | $691.12M | Rp372.00 | -1.59% |
| Kovai Medical Center and Hospital LimitedBSE: 523323 | $682.07M | Rs6,001.50 | -1.55% |
| Starling Oncology, Inc.NasdaqCM: STLN | $655.32M | $6.18 | -3.89% |
| Mediterranean Towers Ltd.TASE: MDTR | $648.56M | ₪13.16 | -0.15% |
| SALUS, Ljubljana, d. d.LJSE: SALR | $648.53M | €70.50 | +0.71% |
| Luyan Pharma Co.,Ltd.SZSE: 002788 | $623.22M | CN¥10.76 | -1.19% |
Figures last refreshed Oct 4, 2026.